SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-040483
Filing Date
2023-05-16
Accepted
2023-05-16 16:30:34
Documents
2
Period of Report
2023-05-16

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea178709-6k_altamira.htm 6-K 9386
2 PRESS RELEASE, DATED AS OF MAY 16, 2023 ea178709ex99-1_altamira.htm EX-99.1 92034
  Complete submission text file 0001213900-23-040483.txt   102769
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000 41 (0) 41 729 71 94
Altamira Therapeutics Ltd. (Filer) CIK: 0001601936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36582 | Film No.: 23928003
SIC: 2834 Pharmaceutical Preparations